1 / 32

Epidemiology and control of Streptococcus pyogenes in the health care setting

Epidemiology and control of Streptococcus pyogenes in the health care setting. Dr Elisabeth Ridgway Consultant Microbiologist Royal Hallamshire Hospital, Sheffield. Lecture outline. The organism The scale and spectrum of streptococcal infection Historical association with health care

jela
Download Presentation

Epidemiology and control of Streptococcus pyogenes in the health care setting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Epidemiology and control of Streptococcus pyogenes in the health care setting Dr Elisabeth Ridgway Consultant Microbiologist Royal Hallamshire Hospital, Sheffield

  2. Lecture outline • The organism • The scale and spectrum of streptococcal infection • Historical association with health care • How common is GAS HCAI? • Control measures • Recognising a problem & when to take action • Dealing with staff & patients • The role of the environment

  3. Streptococcus pyogenes:Microscopic appearance & colonial morphology

  4. Infections caused by Streptococcus pyogenes (GAS) • Superficial diseases pharyngitis, skin & soft tissue infn, erysipelas, impetigo, vaginitis, post-partum infn • Deep infections bacteraemia, necrotising fasciitis, deep soft tissue infn, cellulitis, myositis, puerperal sepsis, pericarditis, meningitis, pneumonia, septic arthritis • Toxin-mediated scarletina, toxic shock-like syndrome • Immunologically mediated rheumatic fever, post-streptococcal GN, reactive arthritis

  5. Group A streptococcal infection Overall disease burden • Each year • 1.8 million new cases of serious infection • at least 500,000 deaths • 110 million cases of soft tissue infection • 610 million cases of pharyngitis • At least 18 million people suffer the consequences of serious GAS diseases

  6. Invasive group A streptococcal infection: UK • UK surveillance historically based on laboratory bacteraemia reports - underestimates invasive infection. • 1990: 563 reports in E&W • PHLS enhanced surveillance of iGAS disease (E&W): 1994-97  650-700 bacteraemia cases p.a

  7. European enhanced surveillance of iGAS disease From January 2003 for 2 years in 11 countries

  8. Bacteraemia & iGAS • Bacteraemia • 2002: 1025 reports • 2003: 1866 (Enhanced surveillance began) • 2004: 1604 • Rate: 2.9/100,000 • (1.9 - 4.1/100,000) • iGAS (strep-EURO) 2.95/100,000 (EW&NI)

  9. Group A streptococcal infection and health care Alexander Gordon (1752-1799) “... seized such women only as were visited, or delivered, by a practitioner or nurse, who had previously attended patients affected by the disease….a specific contagion, or infection.... …I could venture to foretell what women would be affected with the disease, upon hearing by what midwife they were to be delivered..” 1795

  10. Group A streptococcal infection and health care Ignaz Philipp Semmelweis (1818-1865) All students or doctors who enter the wards for the purpose of making an examination must wash their hands thoroughly in a solution of chlorinated lime which will be placed in convenient basins near the entrance of the wards. This disinfection will be considered sufficient for this visit. Between examinations the hands must be washed in soap and water. 1847

  11. Group A streptococcal infection and health care Louis Pasteur (1822-1895) ”It is the nursing and medical staff who carry the microbe from an infected woman to a healthy one…. This water, this sponge, this lint with which you wash or cover a wound, may deposit germs which have the power of multiplying rapidly within the tissue.... If I had the honour of being a surgeon....not only would I use none but perfectly clean instruments, but I would clean my hands with the greatest care...” 1879

  12. How common is GAS cross infection? Bacteraemia and surveillance data Percent HAI

  13. Sweden 4% Finland 10% Denmark 0% Czech Rep 26% UK 8% Germany 12% Romania 4% France 18% Italy 14% Greece 9% strep-EURO data on GAS HAI

  14. Features of GAS HCAI Ontario 1992-2000 • Secondary cases significantly more likely after HA than CA infection. • 10% of HA-iGAS associated with in-hospital transmission. • Overall Mortality 17%. 37% if non-surgical, non-obstetric. • 67% within 72 hours of first positive sample. • 15 hospital outbreaks • Duration 1-13 days (median 7days) • 60% involved only 2 cases (range 1-10) • Only 1 outbreak had symptomatic staff • 60% had at least one asymptomatic HCW Clin Infect Dis 2005;41:334-42

  15. GAS cross infection: Principles of management • Isolate admissions with CA-infection • Prompt recognition of the cross-infection episodes • Identification and control of the source of infection • Identification and treatment of cases and carriers • Appropriate isolation & IC precautions • Environmental decontamination • CDC recommendations (CID 2002; 35:950-9) • Not always as straightforward as it should be!

  16. Patients 4 3 2 1 1 2 No. infected or colonised Sept Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Staff Same patient GAS on a Burns Unit

  17. GAS in hospitals: When to take action? “Even one GAS infection is reason for concern and two or more cases in a short time period should alert the infection control team that a full scale epidemic investigation is warranted.” • High risk units eg. Maternity/neonatal/surgical wards: Single case • Know the epidemiology of your high risk units • Be aware of activity in the community • Store strains from cases and contacts • Type strains to clarify the epidemiology • React quickly & start investigation before results come back – incubation of cases is 1-3 days.

  18. Number of swabs received in RHH lab % positive for GAS Invasive cases Week The hospital is part of the community it serves… Sheffield 2004

  19. Patients 4 3 2 1 1 2 No. infected or colonised Sept Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Staff Same patient GAS on a Burns Unit

  20. GAS in hospitals: Case finding • Identification of all cases and carriers is essential • Passive surveillance is inadequate • Well-taken throat swab 95% sensitive for GAS • Undertake promptly because of rapid transmission. • Screening of patients • Nose, throat • Breaches of skin & mucous membranes

  21. Identifying staff cases & carriers Cases • Symptomatic infection uncommon compared to carriage • CA-NF/pneumonia on ICU  symptoms in 30% HCW (CID 20026; 35:1353-9) • Usually presents within 3-4 days of contact • Illness reporting by staff important. • Transmission to family members uncommon Carriers • GAS carriage sites: anus, vagina, skin, throat • Dissemination is common

  22. Identifying & managing staff carriers • Initially screen those involved directly with the patient • HCW present before & during delivery • HCW in theatre or dressing changes • Sites: anterior nares, throat, vagina, rectum and skin • Positives off until 48 hours of antibiotics • Antibiotic regimen depends on carriage site • Pen+/- rifampicin, clindamycin, oral vancomycin + rifampicin • Screen more widely depending on findings and typing

  23. Managing staff carriers • Check for eradication 7-10 days after completing treatment • Relapses common • Household contacts • Toothbrushes & false teeth • Periodic screens for 12 months • Coordinated effort by ICT and Occupational Health • Identification of contacts • Information & support • Compliance with screening may be an issue

  24. Patients STAFF SCREENING 4 3 2 1 1 2 No. infected or colonised Sept Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Staff Symptomatic Symptomatic GAS on a Burns Unit

  25. GAS cross infection:The role of the environment • GAS can remain viable in the environment for prolonged periods • Inoculation of moistened contaminated dust led to infection as often as contaminated secretions (J Hyg Camb 1958; 56: 280-87) • Contaminated blankets/ nasopharyngeal inoculation of dry contaminated dust did not lead to infection (Am J Hyg 1957; 66: 85-95 and 96-101) • Damaged skin & mucous membranes vulnerable to environmental transmission

  26. GAS cross infection:The role of the environment • Maternity unit: Showerhead(JHI 1985; 6: 304-311) • Dermatology ward: Vinyl sheeting(JHI 1998; 40: 135-140) • Nursing home: Shared wash cloth (EID 2003; 9 (10)) • Gloucestershire nursing home(JHI 1995; 30:162-4) Percent positive (no. tested) Percent positive (no. tested) before cleaning after cleaning Upholstered chairs 93 (15) 8 (12) Carpets 100 (8) 0 (6) Curtains 88 (16) 13 (15) • Thorough cleaning is essential to reduce the risk of environmental contamination

  27. Patients 4 3 2 1 1 2 No. infected or colonised Sept Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Staff Environmental screening GAS on a Burns Unit

  28. GAS cross infection:The role of the environment • Postoperative death from • iGAS sepsis • Same strain retrieved from • anaesthetic trolley 48 hours • after procedure • All staff screened negative • 3 members of extended family • with strain of same serotype • and 2 with different serotypes • Probably pharyngeal carriage • at time of procedure

  29. Group A streptococcal cross infection:Antibiotic prophylaxis • No longer routinely given on burns units • Effective in controlling some outbreaks... • Detention centre (BMJ 1982; 285: 95-6) • Nursing homes (Arch Int Med 1992; 152: 1017-22 & EID 2003; 9(10)) • ... but not others. • Military camp (NEJM 1991; 325: 92-7) • Semi-closed community (Lancet 1980; 2: 498-502) • Need to give to all personnel to be effective • Less acceptable for staff than patients (J Clin Micro 1984;19: 366-70) • Does not replace good infection control practice

  30. GAS HCAI: Conclusions • GAS HCAI is not a new problem • iGAS infections increasing • Recognise HA infection and act promptly • Active management of patients and staff is required in outbreaks • The environment may be implicated in transmission • Consider the role of antibiotic prophylaxis • Outbreaks in some settings may be difficult to control

  31. Thank you - Any questions?

More Related